Estrogen and thrombosis: controversies and common sense

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C. (2009) · BMJ · doi:10.1136/bmj.b2890 · Cited by 709 · see citing works

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

Vlieg, A. V. H., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J. M., & Rosendaal, F. R. (2009) · BMJ · doi:10.1136/bmj.b2921 · Cited by 661 · see citing works

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91926-0 · Cited by 631 · see citing works

Thrombosis in pregnancy: maternal and fetal issues

Greer, I. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10265-9 · Cited by 603 · see citing works

Oral Contraceptives and the Risk of Venous Thrombosis

Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 580 · see citing works

Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events

Christiansen, S. C. (2005) · JAMA · doi:10.1001/jama.293.19.2352 · Cited by 578 · see citing works

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation

Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 472 · see citing works

Venous Thromboembolic Disease and Pregnancy

Marik, P. E., & Plante, L. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707993 · Cited by 466 · see citing works

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001) · BMJ · doi:10.1136/bmj.323.7305.131 · Cited by 454 · see citing works

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91927-9 · Cited by 453 · see citing works

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404 · see citing works

Oral Contraceptives and the Risk of Myocardial Infarction

Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003216 · Cited by 367 · see citing works

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329 · see citing works

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319 · see citing works

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

van den Heuvel, M. W., van Bragt, A. J. M., Alnabawy, A., & Kaptein, M. C. J. (2005) · Contraception · doi:10.1016/j.contraception.2005.03.005 · Cited by 319 · see citing works

Venous Thromboembolism in Pregnancy

James, A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.184127 · Cited by 295 · see citing works

Contraceptive hormone use and cardiovascular disease

Shufelt, C. L., & Bairey Merz, C. N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.042 · Cited by 287 · see citing works

Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).

Høibraaten, E., Qvigstad, E., Arnesen, H., Larsen, S. U., Wickström, E., & Sandset, P. (2000) · PubMed · Cited by 264 · see citing works

Risk assessment for recurrent venous thrombosis

Kyrle, P. A., Rosendaal, F. R., & Eichinger, S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60962-2 · Cited by 263 · see citing works

Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case‐control study

(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259 · see citing works

Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study

Hannaford, P. C., Iversen, L., Macfarlane, T. V., Elliott, A. M., Angus, V., & Lee, A. J. (2010) · BMJ · doi:10.1136/bmj.c927 · Cited by 240 · see citing works

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

Jick, S. S., & Hernandez, R. K. (2011) · BMJ · doi:10.1136/bmj.d2151 · Cited by 236 · see citing works

Oral Contraceptives and the Risk of Myocardial Infarction

Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200205000-00021 · Cited by 225 · see citing works

Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study

Kemmeren, J. M., Tanis, B. C., van den Bosch, M. A. A. J., Bollen, E. L. E. M., Helmerhorst, F. M., van der Graaf, Y., Rosendaal, F. R., & Algra, A. (2002) · Stroke · doi:10.1161/01.str.0000015345.61324.3f · Cited by 220 · see citing works

Mechanisms of estrogen-induced venous thromboembolism

Tchaikovski, S. N., & Rosing, J. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.045 · Cited by 219 · see citing works

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

Curb, J. D., Prentice, R. L., Bray, P. F., Langer, R. D., Horn, L. V., Barnabei, V. M., Bloch, M. J., Cyr, M. G., Gass, M. L. S., Lepine, L. A., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.772 · Cited by 215 · see citing works

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database

Parkin, L., SHARPLES, K. J., Hernandez, R. K., & Jick, S. S. (2011) · BMJ · doi:10.1136/bmj.d2139 · Cited by 203 · see citing works

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Vandenbroucke, J. P., van der Meer, F. J. M., Helmerhorst, F. M., & Rosendaal, F. R. (1996) · BMJ · doi:10.1136/bmj.313.7065.1127 · Cited by 202 · see citing works

Contraceptivos orales y riesgo de infarto de miocardio

Tanis, B. C. (2001) · New England Journal of Medicine · Cited by 192 · see citing works

Estrogens, progestogens and thrombosis

Rosendaal, F. R., Vlieg, A. V. H., Tanis, B. C., & Helmerhorst, F. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00264.x · Cited by 189 · see citing works

The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device

Vlieg, A. V. H., Helmerhorst, F. M., & Rosendaal, F. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.211482 · Cited by 175 · see citing works

The use of newer progestins for contraception

Sitruk-Ware, R. L., & Nath, A. (2010) · Contraception · doi:10.1016/j.contraception.2010.04.004 · Cited by 173 · see citing works

Metabolic effects of contraceptive steroids

Sitruk-Ware, R., & Nath, A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9182-4 · Cited by 161 · see citing works

Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral Contraceptives

Seeger, J. D., Loughlin, J. E., Eng, P. M., Clifford, C. R., Cutone, J. A., & Walker, A. M. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000279448.62221.a8 · Cited by 158 · see citing works

Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial

Kemmeren, J. M., Algra, A., Meijers, J. C. M., Tans, G., Bouma, B. N., Curvers, J., Rosing, J., & Grobbee, D. E. (2004) · Blood · doi:10.1182/blood-2003-04-1285 · Cited by 157 · see citing works

Range of published estimates of venous thromboembolism incidence in young women

Heinemann, L. A. J., & Dinger, J. C. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.018 · Cited by 149 · see citing works

Levonorgestrel-Releasing Intrauterine System or Medroxyprogesterone for Heavy Menstrual Bleeding

Kaunitz, A. M., Bissonnette, F., MONTEIRO, I. M. U., Lukkari‐Lax, E., Muysers, C., & Jensen, J. T. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181ec622b · Cited by 145 · see citing works

A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

Farmer, R. D. T., Lawrenson, R. A., Todd, J. ‐., Williams, T. J., MacRae, K. D., Tyrer, F., & Leydon, G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00198.x · Cited by 130 · see citing works

Hormones and cardiovascular health in women

The ESHRE Capri Workshop Group (2006) · Human Reproduction Update · doi:10.1093/humupd/dml028 · Cited by 106 · see citing works

Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol

Jick, S. S., Kaye, J. A., Li, L., & Jick, H. (2007) · Contraception · doi:10.1016/j.contraception.2007.03.003 · Cited by 106 · see citing works

Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up

Chi, C., HUQ, F. Y., & Kadir, R. A. (2010) · Contraception · doi:10.1016/j.contraception.2010.07.010 · Cited by 99 · see citing works

Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol

Goebelsmann, U., Mashchak, C. A., & Mishell, D. R. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90664-7 · Cited by 99 · see citing works

The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women

van den Bosch, M. A. A. J., Kemmeren, J. M., Tanis, B. C., Mali, W. P. T. M., Helmerhorst, F. M., Rosendaal, F. R., Algra, A., & van der Graaf, Y. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00079.x · Cited by 87 · see citing works

Clinical Factors and Recurrent Venous Thrombotic Events

Flansbaum, B. E. (2005) · JAMA · doi:10.1001/jama.294.12.1489-a · Cited by 81 · see citing works

Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users

Dore, D. D., Norman, H. S., Loughlin, J. E., & Seeger, J. D. (2010) · Contraception · doi:10.1016/j.contraception.2009.12.009 · Cited by 78 · see citing works

Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: A cross-over study

Fleischer, K., Vliet, H. A. V., Rosendaal, F. R., Rosing, J., Tchaikovski, S. N., & Helmerhorst, F. M. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.04.022 · Cited by 68 · see citing works

Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders

Lukes, A. S., Reardon, B., & Arepally, G. M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1315 · Cited by 64 · see citing works

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

Lijfering, W. M., Veeger, N. J. G. M., Middeldorp, S., Hamulyák, K., Prins, M. H., Buller, H. R., & van der Meer, J. (2009) · Blood · doi:10.1182/blood-2009-04-215418 · Cited by 61 · see citing works

Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis

Jensen, J. T., Burke, A. E., Barnhart, K. T., Tillotson, C. J., Messerle-Forbes, M., & Peters, D. (2008) · Contraception · doi:10.1016/j.contraception.2008.07.004 · Cited by 47 · see citing works

Epidemiology of the contraceptive pill and venous thromboembolism

Hannaford, P. C. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70009-3 · Cited by 45 · see citing works

Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

Jensen, J. T. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003724713 · Cited by 45 · see citing works

Postmenopausal hormone therapy and venous thromboembolism

Olié, V., Canonico, M., & Scarabin, P. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70008-1 · Cited by 42 · see citing works

Oral contraceptives and the risk of myocardial infarction

Tanis, B. C., van den Bosch, M. A., & Kemmeren, J. M. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00660-8 · Cited by 39 · see citing works

Prescribing Oral Contraceptives for Women Older Than 35 Years of Age

Seibert, C. S., Barbouche, E., Fagan, J. M., Myint, E., Wetterneck, T. B., & Wittemyer, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00013 · Cited by 39 · see citing works

Hormone therapy and thromboembolic disease

Battaglioli, T., & Martinelli, I. (2007) · Current Opinion in Internal Medicine · doi:10.1097/moh.0b013e32825f5302 · Cited by 38 · see citing works

Corrections

(2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181f80a37 · Cited by 36 · see citing works

Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin®

Pearce, H., Layton, D., Wilton, L., & Shakir, S. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02373.x · Cited by 35 · see citing works

Surrogate end points in women's health research: science, protoscience, and pseudoscience

Grimes, D. A., Schulz, K. F., & Raymond, E. G. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.12.054 · Cited by 35 · see citing works

A Benefit-Risk Review of Systemic Haemostatic Agents

Fraser, I. S., Porte, R. J., Kouides, P. A., & Lukes, A. S. (2008) · Drug Safety · doi:10.2165/00002018-200831040-00001 · Cited by 34 · see citing works

ORTHO EVRA® and venous thromboembolism: an update

Jick, S. S., Hagberg, K. W., & Kaye, J. A. (2010) · Contraception · doi:10.1016/j.contraception.2009.12.016 · Cited by 32 · see citing works

Probable Drug Interaction Between Warfarin and Hormonal Contraceptives

Farland, M. Z., Guirguis, A. B., Airee, A., & Cobb, D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m382 · Cited by 32 · see citing works

Oral contraception and thrombophilia

Blickstein, D., & Blickstein, I. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32821642e6 · Cited by 30 · see citing works

Oral contraceptives and the risk of myocardial infarction

Tanis, B. C. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00752-2 · Cited by 27 · see citing works

Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products

Sehovic, N., & Smith, K. P. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m649 · Cited by 25 · see citing works

Controversies in contraception

Pitts, S., & Emans, S. J. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328305e13f · Cited by 23 · see citing works

Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy

DeSancho, M. T., Dorff, T. B., & Rand, J. H. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32833b2b84 · Cited by 19 · see citing works

Third-generation oral contraceptives: how risky?

Weiss, N. S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91921-x · Cited by 18 · see citing works

Venous thromoboembolic disease and pregnancy

Martineau, M., & Nelson‐Piercy, C. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.079822 · Cited by 16 · see citing works

Oral contraceptives and venous thromboembolism

Dunn, N. R. (2009) · BMJ · doi:10.1136/bmj.b3164 · Cited by 15 · see citing works

The risk of deep venous thrombosis with oral contraceptives containing drospirenone

Dunn, N. (2011) · BMJ · doi:10.1136/bmj.d2519 · Cited by 13 · see citing works

On Cardiovascular Health in Women

Theorell, T. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3712-0_10 · Cited by 11 · see citing works

2047 Consistent benefit of clopidogrel in patients with non-ST-elevation acute coronary syndromes undergoing very early, early or later percutaneous coronary intervention in the CURE study

Lewis, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)95044-5 · Cited by 11 · see citing works

Oral administration of methylergometrine shows a late and unpredictable effect on the non-pregnant human menstruating uterus

de Groot, A. N. J. A., van Dongen, P. W. J., Vree, T. B., & Eskes, T. K. A. B. (1995) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(95)02100-7 · Cited by 7 · see citing works

Menstrual regulation in women with von Willebrand's disease

Hicks, S., DeLoughery, T. G., & Edelman, A. B. (2008) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.01.020 · Cited by 1 · see citing works

Estrogen and thrombosis: a bench to bedside review

Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.008 · Cited by 261 · see citing works

Estrogen and estrogen receptors in kidney diseases

Ma, H.-Y., Chen, S., & Du, Y. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1901739 · Cited by 148 · see citing works

Sex, stroke, and inflammation: The potential for estrogen-mediated immunoprotection in stroke

Ritzel, R. M., Capozzi, L. A., & McCullough, L. D. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.04.007 · Cited by 107 · see citing works

The Sexual Dimorphism Associated with Pulmonary Hypertension Corresponds to a Fibrotic Phenotype

Rafikova, O., Rafikov, R., Meadows, M. L., Kangath, A., Jonigk, D. D., & Black, S. M. (2015) · Pulmonary Circulation · doi:10.1086/679724 · Cited by 57 · see citing works

Combined Oral Contraceptives in Polycystic Ovary Syndrome – Indications and Cautions

Bozdağ, G., & Yıldız, B. O. (2012) · Frontiers of hormone research · doi:10.1159/000341823 · Cited by 28 · see citing works

Cerebral Venous Sinus Thrombosis

Krajíčková, D., Klzo, Ľ., Krajina, A., Vyšata, O., Herzig, R., & Vališ, M. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615576739 · Cited by 21 · see citing works

Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy

DeSancho, M. T., Dorff, T. B., & Rand, J. H. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32833b2b84 · Cited by 19 · see citing works

Evaluation of activity of hypothalamo-pituitary-gonadal axis in postmenopausal women suffering from severe acute illness

Suresh, V., Raj, M., Mukka, A., Reddy, A., Sachan, A., Mohan, A., Vengamma, B., & Rao, P. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.178596 · Cited by 11 · see citing works

Impact of severity of illness on the function of the hypothalamo-pituitary-gonadal axis in postmenopausal women with acute severe illness: Implications for predicting disease outcome

Vaikkakara, S., Raj, M., Sachan, A., Mohan, A., Vengamma, B., Rao, P., Mukka, A., Sravani, C., & Reddy, A. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_398_16 · Cited by 5 · see citing works

Life-Threatening Complications of Hormonal Contraceptives: A Case History

Khan, S., Smulders, Y. M., de Vries, J. I. P., & de Man, A. (2013) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2013/186230 · Cited by 5 · see citing works

Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database

Arias, L. H. M., Sáinz-Gil, M., Navarro-García, E., Valdivieso, I. S., & Fadrique, R. S. (2022) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00282-3 · Cited by 4 · see citing works

Le risque de thrombose veineuse profonde lors d’un voyage en avion : prévention et conseil à l’officine

Zawieja, P. P., Orecchioni, A., Métais, P., & Touze, J. E. (2011) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2011.06.004 · Cited by 2 · see citing works

Recusa e informação: os casos dos contraceptivos hormonais e seus efeitos “colaterais”

Pissolito, C., & Manica, D. T. (2023) · Ilha Revista de Antropologia · doi:10.5007/2175-8034.2023.e85644 · Cited by 1 · see citing works

High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states

Agarwal, T., Mereuta, O. M., Ghozy, S. A., Larco, J. A., Bilgin, C., Kadirvel, R., Brinjikji, W., & Kallmes, D. F. (2024) · BMC Neurology · doi:10.1186/s12883-024-03579-2 · Cited by 1 · see citing works

A nomogram clinical model for predicting preoperative lower limb venous thrombosis in knee ligament injuries: a retrospective study

Duan, J., Xiao, T., Xing, T., Qin, W. D., Wang, Z., Dou, H., Wu, D., & Du, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1486625 · Cited by 1 · see citing works

Oocyte cryopreservation in a patient with paroxysmal nocturnal hemoglobinuria

Wan, Q., Meng, X., Chen, Y., & Zheng, A. (2022) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2021.12.057 · Cited by 1 · see citing works

Bleeding and Thrombosis: Women’s Issues

DeLoughery, T. G. (2014) · Springer eBooks · doi:10.1007/978-3-319-09312-3_29

References

(2016) · Duke University Press eBooks · doi:10.1215/9780822374190-009

Current World Literature

(2012) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3283564f02

Pharmakologie

Bauersachs, R. M., Kröger, M., Schrör, K., Hohlfeld, T., Spannagl, M., & Hart, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-21496-7_5

Huoxue Qushi medicine mud attenuates the deep venous thrombosis formation through inhibiting the NLRP3 inflammasome-mediated inflammatory responses in platelets

Chen, Y., Bao, Z., Li, Y., Luo, L., Cai, J., Wang, C., & Luo, Q. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103558

[Contraception and thromboembolic vascular complications].

Jaillard, J. (1971) · PubMed

Hormone Replacement Therapy and Cardiovascular Disease

Turek, M. A., & Derzko, C. M. (2002) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(17)31078-2 · Cited by 8 · see citing works

Estrogen and thrombosis: a bench to bedside review

Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.008 · Cited by 261 · see citing works

Hormones and thrombosis: the dark side of the moon.

Barcellona, D., Grandone, E., & Marongiu, F. (2024) · PubMed Central · doi:10.2450/bloodtransfus.535 · Cited by 9 · see citing works

Hormonal therapies and venous thrombosis: Considerations for prevention and management

Lavasseur, C. M., Neukam, S., Kartika, T., Bannow, B. S., Shatzel, J. J., & DeLoughery, T. G. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12763 · Cited by 103 · see citing works